Periodontal inflammation is associated with increased circulating levels of endothelial progenitor cells: a retrospective cohort study in a high vascular risk population.
María Vázquez-Reza, Antía Custodia, Iria López-Dequidt, Marta Aramburu-Núñez, Daniel Romaus-Sanjurjo, Alberto Ouro, João Botelho, Vanessa Machado, Ramón Iglesias-Rey, Juan Manuel Pías-Peleteiro, Rogelio Leira, Juan Blanco, José Castillo, Tomás Sobrino, Yago Leira
{"title":"Periodontal inflammation is associated with increased circulating levels of endothelial progenitor cells: a retrospective cohort study in a high vascular risk population.","authors":"María Vázquez-Reza, Antía Custodia, Iria López-Dequidt, Marta Aramburu-Núñez, Daniel Romaus-Sanjurjo, Alberto Ouro, João Botelho, Vanessa Machado, Ramón Iglesias-Rey, Juan Manuel Pías-Peleteiro, Rogelio Leira, Juan Blanco, José Castillo, Tomás Sobrino, Yago Leira","doi":"10.1177/20406223231178276","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>One of the main biological mechanisms behind the link between periodontitis and atherosclerotic vascular diseases is vascular endothelial dysfunction. Particularly, circulating endothelial progenitor cells (EPCs) have been considered a biomarker of altered vascular endothelial function.</p><p><strong>Objectives: </strong>The aim of this study was to investigate relationship between periodontal inflammation and increased number of circulating EPCs.</p><p><strong>Design: </strong>This is retrospective cohort study.</p><p><strong>Methods: </strong>In this study, 85 elderly patients with a previous history of hypertension were followed up to 12 months. A baseline full-mouth periodontal assessment was carried out, and the amount of periodontal tissue inflamed per subject was calculated as a proxy of periodontal inflammation [periodontal inflamed surface area (PISA)]. The number of circulating EPCs (CD34<sup>+</sup>/CD133<sup>+</sup>/KDR<sup>+</sup>) was determined by flow cytometry from peripheral blood samples collected at baseline and 12 months.</p><p><strong>Results: </strong>Mean concentrations of CD34<sup>+</sup>/CD133<sup>+</sup>/KDR<sup>+</sup> progenitor cells were higher in periodontitis patients than in those without periodontitis at baseline [55.4, 95% confidence interval (CI) = 20.8 to 90.0 <i>versus</i> 27.2, 95% CI = 13.6 to 40.8, <i>p</i> = 0.008] and 12 months (114.6, 95% CI = 53.5 to 175.7 <i>versus</i> 19.1, 95% CI = 10.8 to 27.4, <i>p</i> = 0.003). A significant increase over the follow-up was noticed in the group of subjects with periodontitis (<i>p</i> = 0.049) but not in the nonperiodontitis group (<i>p</i> = 0.819). PISA was independently associated with CD34<sup>+</sup>/CD133<sup>+</sup>/KDR<sup>+</sup> EPCs at baseline (<i>B</i> coefficient = 0.031, 95% CI = 0.005 to 0.058; <i>p</i> = 0.021). The relationship between PISA and CD34<sup>+</sup>/CD133<sup>+</sup>/KDR<sup>+</sup> EPCs at 12 months was confounded by increased baseline body mass index (<i>B</i> coefficient = 0.064, 95% CI = -0.005 to 0.132; <i>p</i> = 0.066).</p><p><strong>Conclusion: </strong>Periodontal inflammation is associated with high number of CD34<sup>+</sup>/CD133<sup>+</sup>/KDR<sup>+</sup> EPCs, thus supporting a potential link between periodontitis and endothelial dysfunction.</p>","PeriodicalId":22960,"journal":{"name":"Therapeutic Advances in Chronic Disease","volume":"14 ","pages":"20406223231178276"},"PeriodicalIF":3.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/46/49/10.1177_20406223231178276.PMC10285583.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Chronic Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/20406223231178276","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: One of the main biological mechanisms behind the link between periodontitis and atherosclerotic vascular diseases is vascular endothelial dysfunction. Particularly, circulating endothelial progenitor cells (EPCs) have been considered a biomarker of altered vascular endothelial function.
Objectives: The aim of this study was to investigate relationship between periodontal inflammation and increased number of circulating EPCs.
Design: This is retrospective cohort study.
Methods: In this study, 85 elderly patients with a previous history of hypertension were followed up to 12 months. A baseline full-mouth periodontal assessment was carried out, and the amount of periodontal tissue inflamed per subject was calculated as a proxy of periodontal inflammation [periodontal inflamed surface area (PISA)]. The number of circulating EPCs (CD34+/CD133+/KDR+) was determined by flow cytometry from peripheral blood samples collected at baseline and 12 months.
Results: Mean concentrations of CD34+/CD133+/KDR+ progenitor cells were higher in periodontitis patients than in those without periodontitis at baseline [55.4, 95% confidence interval (CI) = 20.8 to 90.0 versus 27.2, 95% CI = 13.6 to 40.8, p = 0.008] and 12 months (114.6, 95% CI = 53.5 to 175.7 versus 19.1, 95% CI = 10.8 to 27.4, p = 0.003). A significant increase over the follow-up was noticed in the group of subjects with periodontitis (p = 0.049) but not in the nonperiodontitis group (p = 0.819). PISA was independently associated with CD34+/CD133+/KDR+ EPCs at baseline (B coefficient = 0.031, 95% CI = 0.005 to 0.058; p = 0.021). The relationship between PISA and CD34+/CD133+/KDR+ EPCs at 12 months was confounded by increased baseline body mass index (B coefficient = 0.064, 95% CI = -0.005 to 0.132; p = 0.066).
Conclusion: Periodontal inflammation is associated with high number of CD34+/CD133+/KDR+ EPCs, thus supporting a potential link between periodontitis and endothelial dysfunction.
期刊介绍:
Therapeutic Advances in Chronic Disease publishes the highest quality peer-reviewed research, reviews and scholarly comment in the drug treatment of all chronic diseases. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers involved in the medical treatment of chronic disease, providing a forum in print and online for publishing the highest quality articles in this area.